Abstract

Stem cells, progenitor cells, and lineage-committed cells are being considered as a new generation of drug depots for the sustained release of therapeutic biomolecules. Hydrogels are often used in conjunction with the therapeutic secreting cells to provide a physical barrier to protect the cells from hostile extrinsic factors. Although the hydrogels significantly improve the therapeutic efficacy of transplanted cells, there have been no successful products commercialized based on these technologies. Recently, biomaterials are increasingly designed to provide cells with both a physical barrier and an extracellular matrix to further improve the secretion of therapeutic proteins from cells. This review will discuss (1) the cell encapsulation process, (2) the immunogenicity of the encapsulating hydrogel, (3) the transport properties of the hydrogel, (4) the hydrogel mechanical properties, and will propose new strategies to improve the hydrogel and cell interaction for successful cell-based drug delivery strategies.

Original languageEnglish (US)
Pages (from-to)1113-1122
Number of pages10
JournalJournal of Biomedical Materials Research - Part A
Volume87
Issue number4
DOIs
StatePublished - Dec 15 2008

Fingerprint

Hydrogels
Hydrogel
Drug delivery
Biocompatible Materials
Biomolecules
Stem cells
Encapsulation
Transport properties
Biomaterials
Mechanical properties
Pharmaceutical Preparations
Proteins

Keywords

  • Biocompatibility
  • Biomolecular transport
  • Cell viability
  • Stiffness
  • Therapeutic protein

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys

Cite this

Hydrogels used for cell-based drug delivery. / Schmidt, John J.; Rowley, Jon; Hyun, Joon Kong.

In: Journal of Biomedical Materials Research - Part A, Vol. 87, No. 4, 15.12.2008, p. 1113-1122.

Research output: Contribution to journalReview article

Schmidt, John J. ; Rowley, Jon ; Hyun, Joon Kong. / Hydrogels used for cell-based drug delivery. In: Journal of Biomedical Materials Research - Part A. 2008 ; Vol. 87, No. 4. pp. 1113-1122.
@article{8d2afb967372463396767108b912e1e5,
title = "Hydrogels used for cell-based drug delivery",
abstract = "Stem cells, progenitor cells, and lineage-committed cells are being considered as a new generation of drug depots for the sustained release of therapeutic biomolecules. Hydrogels are often used in conjunction with the therapeutic secreting cells to provide a physical barrier to protect the cells from hostile extrinsic factors. Although the hydrogels significantly improve the therapeutic efficacy of transplanted cells, there have been no successful products commercialized based on these technologies. Recently, biomaterials are increasingly designed to provide cells with both a physical barrier and an extracellular matrix to further improve the secretion of therapeutic proteins from cells. This review will discuss (1) the cell encapsulation process, (2) the immunogenicity of the encapsulating hydrogel, (3) the transport properties of the hydrogel, (4) the hydrogel mechanical properties, and will propose new strategies to improve the hydrogel and cell interaction for successful cell-based drug delivery strategies.",
keywords = "Biocompatibility, Biomolecular transport, Cell viability, Stiffness, Therapeutic protein",
author = "Schmidt, {John J.} and Jon Rowley and Hyun, {Joon Kong}",
year = "2008",
month = "12",
day = "15",
doi = "10.1002/jbm.a.32287",
language = "English (US)",
volume = "87",
pages = "1113--1122",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "Heterocorporation",
number = "4",

}

TY - JOUR

T1 - Hydrogels used for cell-based drug delivery

AU - Schmidt, John J.

AU - Rowley, Jon

AU - Hyun, Joon Kong

PY - 2008/12/15

Y1 - 2008/12/15

N2 - Stem cells, progenitor cells, and lineage-committed cells are being considered as a new generation of drug depots for the sustained release of therapeutic biomolecules. Hydrogels are often used in conjunction with the therapeutic secreting cells to provide a physical barrier to protect the cells from hostile extrinsic factors. Although the hydrogels significantly improve the therapeutic efficacy of transplanted cells, there have been no successful products commercialized based on these technologies. Recently, biomaterials are increasingly designed to provide cells with both a physical barrier and an extracellular matrix to further improve the secretion of therapeutic proteins from cells. This review will discuss (1) the cell encapsulation process, (2) the immunogenicity of the encapsulating hydrogel, (3) the transport properties of the hydrogel, (4) the hydrogel mechanical properties, and will propose new strategies to improve the hydrogel and cell interaction for successful cell-based drug delivery strategies.

AB - Stem cells, progenitor cells, and lineage-committed cells are being considered as a new generation of drug depots for the sustained release of therapeutic biomolecules. Hydrogels are often used in conjunction with the therapeutic secreting cells to provide a physical barrier to protect the cells from hostile extrinsic factors. Although the hydrogels significantly improve the therapeutic efficacy of transplanted cells, there have been no successful products commercialized based on these technologies. Recently, biomaterials are increasingly designed to provide cells with both a physical barrier and an extracellular matrix to further improve the secretion of therapeutic proteins from cells. This review will discuss (1) the cell encapsulation process, (2) the immunogenicity of the encapsulating hydrogel, (3) the transport properties of the hydrogel, (4) the hydrogel mechanical properties, and will propose new strategies to improve the hydrogel and cell interaction for successful cell-based drug delivery strategies.

KW - Biocompatibility

KW - Biomolecular transport

KW - Cell viability

KW - Stiffness

KW - Therapeutic protein

UR - http://www.scopus.com/inward/record.url?scp=56749102792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749102792&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.32287

DO - 10.1002/jbm.a.32287

M3 - Review article

C2 - 18837425

AN - SCOPUS:56749102792

VL - 87

SP - 1113

EP - 1122

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 4

ER -